Institut de Cancerologie de L'Ouest (Ico)
Angers, 49055, France
NCT Number: NCT05343975
A prospective, non-randomized, single-center cohort study to evaluate the value of audio-guided meditation during breast biopsy procedures.
The main criterion of judgment is based on the evaluation of tolerance, which includes anxiety and pain felt. This is assessed with questionnaires (STAI-ETAT and EN) before and after the procedure.
Secondary endpoints include tolerance of additional physical pain, reduction in the number of per-procedure complications, overall satisfaction of the practitioner with the biopsy procedure, and comparison of the tolerance of the procedure in patients who practice meditation at home before the procedure
Looking for future studies?
Notify Me18 year and older
Female
Observational
Angers, 49055, France
audio-guided meditation during breast biopsy procedures questionnaires (STAI-ETAT and EN) before and after the procedure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
biopsy with audio-guided Meditation
Time frame: immediately after procedure
11-point numerical scale (from 0 = no pain to 10 = maximal pain)
Time frame: immediately after procedure
State Trait Anxiety Inventory Etat - Trait (40 questions - each item has a score from 1 to 4 (4 being the highest level of anxiety))
Time frame: immediately after procedure (same day of the biopsy)
complications
Time frame: immediately after procedure
questions about 1. overall quality of the doctor-patient relationship and 2. Patient compliance with the procedure with scales in 4 point
Time frame: immediately after procedure
number of samples taken in the target
Institut Cancerologie de l'Ouest
Other
Acronym: MAG-BM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06886659
Antineoplastic Agents, Breast Cancer
Dhaka, Bangladesh
View Trial DetailsNCT00639535
Breast Disease, Breast Diseases
Liverpool, New York, United States
View Trial DetailsNCT06025461
Breast Disease, Breast Diseases
Shandong, China
View Trial DetailsNCT06026176
Breast Disease, Breast Diseases
Dharān, Koshi, Nepal
View Trial Details